Skip to main content

A hub for global health at Scripps Research.

New technologies, drugs, therapeutics, diagnostics and vaccines are needed to detect, prevent and cure diseases that impact some of the most vulnerable populations in the world. We need to mobilize experts from a broad spectrum of scientific fields—from chemists and immunologists, to geneticists and bioinformaticians—to accelerate progress.

Ranked #1 in the world for innovation by Nature Index, Scripps Research has a long history of excellence in infectious disease research. Our scientists tackle problems from both basic and translational research angles, resulting in deep mechanistic insights into the biology, immunology, and epidemiology of some of the most severe human diseases, as well as new medicines for diverse unmet medical needs. Our research drives real change in global health, including the development of promising vaccine candidates for HIV, influenza and malaria, novel immunotherapeutics and drugs for neglected tropical diseases, and new methods for rapid detection of infectious disease outbreaks.

The Global Health Initiative at Scripps Research seeks to build a broad network of local, national and international collaborations with academia, industry and government, to further our commitment to reducing the burden of disease worldwide. With our top-ten ranked doctoral program that promotes interdisciplinary training, we also strive to educate and inspire the next generation of scientists dedicated to the elimination and eradication of infectious diseases.